Axiron Topical Solution

Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XRPerrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen